Corrigendum: Tofacitinib Induction and Maintenance Therapy in East Asian Patients With Active Ulcerative Colitis: Subgroup Analyses From Three Phase 3 Multinational Studies

Intestinal Research - South Korea
doi 10.5217/ir.2018.16.3.499
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Korean Association for the Study of Intestinal Diseases

Related search

Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

New England Journal of Medicine
Medicine
2005English

Combination Therapy With Vedolizumab and Tofacitinib in a Patient With Ulcerative Colitis and Spondyloarthropathy

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

EFFICACY AND SAFETY OF TOFACITINIB IN ULCERATIVE COLITIS (Review)

Koloproktologia
2018English

AB0794 Effect of Tofacitinib on Patient-Reported Outcomes in Patients With Active Psoriatic Arthritis: Results From Two Phase 3 Studies

2017English

Red Cell Abnormalities Associated With Sulphasalazine Maintenance Therapy for Ulcerative Colitis.

Gut
Gastroenterology
1975English

Randomized Trial of Tofacitinib in Active Ulcerative Colitis: Analysis of Efficacy Based on Patient-Reported Outcomes

BMC Gastroenterology
MedicineGastroenterology
2015English

Clinical and Radiological Studies on Radiological Signs of Ischemic Colitis in Patients With Ulcerative Colitis

Juntendo Medical Journal
1987English

Efficacy and Safety of Biologic Agents and Tofacitinib in Moderate-To-Severe Ulcerative Colitis: A Systematic Overview of Meta-Analyses

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy